SEEN, the hair care brand developed by Harvard-trained dermatologist Dr. Iris Rubin, has closed $9 million in Series A funding. This funding will accelerate SEEN’s growth as a premier science-backed and clinically proven beauty brand. Participants include Mitch Ralls, co-founder of Danaher Corporation; Somerville SPV, led by prominent investor Feroz Dewan. Sator Grove Holdings, permanent capital investor; and George Mrkonic, director of Ulta Beauty. SEEN also received early financial support from prominent Harvard dermatologists and scientists, including Dr. Rox Anderson of Harvard University/Massachusetts General Hospital.
SEEN is a pioneer in the transformation of hair care into skin, bridging the gap between luxury hair care and skin care. And the brand’s success stems from Dr. Rubin’s groundbreaking insight that hair products can clog pores and irritate the skin, leading to problems like acne and eczema. Dr. Rubin, who has suffered from breakouts for years, pinpointed the culprit to hair products. After four years of development, SEEN launched three major hair products in 2019 and has since grown into a complete line of hair care and styling products.
SEEN applies rigorous dermatology and testing to its formulations. SEEN’s Epidermal Rebalancing Technology also uses effective skin-friendly ingredients to develop hair and body products that deliver stronger, smoother, healthier-looking hair and healthier-looking skin. Masu. SEEN has 5 patents, over 7,000 5-star reviews, over 10 beauty awards, and its unscented line holds the National Eczema Association Seal of Approval .
Main quotation:
“This is another transformational milestone for SEEN. The majority of U.S. adults self-identify as having sensitive skin, and more than 100 million Americans suffer from acne, eczema, dry scalp, and hair loss. can be exacerbated by irritating, allergenic, and pore-clogging ingredients in hair products. Our mission is to provide salon-quality hair formulas that are clinically proven to be gentle on the skin. , to help people look confident.”
-Dr. Iris Rubin, co-founder of SEEN
“Series A funding will enable us to focus on innovation, expand our specialty sampling to an additional 10,000 dermatology practices in 2025, and expand our retail footprint. Since then, we have achieved 100% compound annual growth and consistently exceeded Ulta’s brand sales forecasts.”
-Greg Maged, SEEN Co-Founder
“We are excited to be an investor in SEEN and believe it is setting a new standard in performance hair care. SEEN applies dermatology to hair care, which is exactly what excites Ulta. It is the type of innovation that defines the category.”
-Investor George Murconick, currently a director at Ulta Beauty
“When we invest in brands, we look for companies with significant market potential, high margins, and platforms that create unique benefits for consumers. We also look for companies that are smart, agile, and committed to excellence. We also want to invest in leadership driven by passion, and SEEN embodies all of these qualities.”
-Mitch Lares, SEEN Investor
